SCHEMBL7797702

SCHEMBL7797702

CCCCCCCC(C)CCCO

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.57
ALDH1A1 P00352 2/20 0.57
HSD17B10 Q99714 1/20 0.57
MEN1 O00255 1/20 0.57
KMT2A Q03164 1/20 0.57
TSHR P16473 1/20 0.57
ACE2 Q9BYF1 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.52
PRKD3 O94806 1/20 0.49
PRKCG P05129 1/20 0.49
PRKCB P05771 1/20 0.49
PRKCA P17252 1/20 0.49
PRKCH P24723 1/20 0.49
PRKCI P41743 1/20 0.49
PRKCE Q02156 1/20 0.49
PRKCQ Q04759 1/20 0.49
PRKCZ Q05513 1/20 0.49
PRKCD Q05655 1/20 0.49
PRKD1 Q15139 1/20 0.49
SPHK1 Q9NYA1 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1658300 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL15048504 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL6158737 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL27696843 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL15478674 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL2223810 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL2226904 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL15478675 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL3369083 1.00 LMNA (0.57) LMNAALDH1A1HSD17B10MEN1KMT2A
SCHEMBL2224957 0.98 ACE2 (0.55) LMNAALDH1A1HSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220408724-A1 METHOD FOR CONTROLLING METABOLISM OF BRANCHED FATTY ACID KAO CORPORATION (JP) 2022-12-29 US disclosed
EP-4067475-A1 METHOD FOR CONTROLLING BRANCHED FATTY ACID METABOLISM Kao Corporation (JP) 2022-10-05 EP disclosed
CN-114761540-A Method for controlling metabolism of branched-chain fatty acids 花王株式会社 2022-07-15 CN disclosed
EP-1113783-A1 COSMETIC COMPOSITIONS CONTAINING HIGHER ALKYL ACETATES AS EMOLLIENTS ExxonMobil Chemical Patents Inc. (US) 2001-07-11 EP disclosed
WO-2000015190-A1 COSMETIC COMPOSITIONS CONTAINING HIGHER ALKYL ACETATES AS EMOLLIENTS EXXON CHEMICAL PATENTS INC. (US) 2000-03-23 WO disclosed
US-6010998-A C9 TO C12 OLEFINS, C9 TO C12 ALCOHOLS AND ACETATES THEREOF. EXXON CHEMICAL PATENTS, INC. (US) 2000-01-04 US disclosed
US-H1818-H Detergent and cleaning compositions derived from new detergent alcohols SASOL TECHNOLOGY (PROPRIETARY) LIMITED (ZA) 1999-11-02 US disclosed
WO-1998051770-A1 CLEANING COMPOSITION CONTAINING PINE OIL EXTENDERS EXXON CHEMICAL PATENTS INC. (US) 1998-11-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220408724-A1 METHOD FOR CONTROLLING METABOLISM OF BRANCHED FATTY ACID FASN, FAR1, FADS1 LMNA 2924/4885ALDH1A1 321/4885HSD17B10 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.